Member Info for teabiscuit

Toffy, this is the AIM market, if you want a sense of certainty then the FTSE 100 will give you that but I am certain you are smart and know that this is the share to be in right now hence you bought back in. So you lost a few thousand, that is the price for knowledge that will help you in the future. Just enjoy the ride and in future stay calm and don't let those emotions decide your trading decisions. The fundamentals always win out in the end.

I feel sorry for those who panicked and sold today, there is no need, even with these shares added the number of shares in issue is still tiny for what this company is about to achieve. A lot of sudden derampers (bears) turned up who had never been on this board before.

Every stay calm, both bulls and bears, the underlying fundamentals is excellent, don't allow an RNS blind you to what this company is achieving. If you think this company will be less than £3 in a few weeks when production is started with less than 50 million in issue you are having a laugh. Do the basic numbers, at around 48 million shares at £4 a share thats approx 192 million mcap. That is still below NCYT and GRD have better tests which are more effective. They also have the new hepatitis test now prelisted via WHO and they have the infant hearing drug test which is going to be massive for a lot of people.

This company is going places and you have to spend money to make money, nothing comes for free, so don't be so greedy and expect to make your millions in a day. In a few weeks from now people will be kicking themselves they didn't buy in at this current price.

Keep in mind this part of the RNS just released that most probably did not bother to read...

"On 20 April 2020, genedrive announced that it had entered into a development agreement with Cytiva (formerly GE Healthcare Life Sciences) to allow for high throughput manufacturing of over 10,000 tests per hour. genedrive has also secured sufficient supply chain commitments for the most critical components to enable the manufacturing of six million tests. The Company anticipates launching the Genedrive® 96-SARS-CoV-2 in May 2020 at an estimated price of £8-10 per test. The Company will address the market on a non-exclusive basis with sales through an appropriate mix of distributors and direct to customers. The Directors believe that based on its sales volume forecasts and estimates of selling prices in the market, the Company will be able to achieve attractive gross margins of at least 60%, noting genedrive does not fully absorb labour costs into its margins."

Gross margin of 60%, the BOD are not stupid they know they have a real gem, be smart like them, they have got this company this far that takes intelligence, that is what you want to invest in.

JAG you opinion is worth the square root of zero. You aren't invested and have no intention of just being friendly to be investors. You are doing the opposite and hurting new investors. There are a lot of knowledgeable people on this board who have done their research and understand the true value that GDR will bring investors. You are not important nor have you any history of contributing to this board so keep acting like you care but you type of guys are ten a penny.

GDR mcap less than 80 million
NCYT mcap 264 million

GDR stable at room temperature to lab
NCYT requires refrigeration to lab

GDR a multiple times of test will be available compared to NCYT.

There is no comparison, GDR will be far superior to NCYT. There is space for both companies to easily share the market.

Institutional Investors now can join the GDR party now its over the 50 mcap and so classed as micro cap share.

Share target has to be 400p + for GDR

pumpky; it is a better test than NCYT due to the fact the test can be stored at room temperature and the volume of testing far exceeds that of NCYT. With the market cap so low for GDR and where they are in the process this is going to have a big re-rate at some point soon. Easily has the potential to get to a £3 - £4 share price in the coming weeks.

Just one mm holding it back on 107. We have to expect peaks and troughs but the overall pattern is a rising share price each week. As soon as initial sales orders come in this will easily be over £2 if it's not already at that price. The Mcap is so low for what awaits in the weeks ahead.

my buys today are showing as sells...

I'm in both GDR and AVCT, both have fantastic potential both from helping us combat the Coronavirus from a test point of view and for the shareholders a substantial profit could be made. A lot of AVCT share price rise is based on the potential of its test, a simple sample of saliva on the test swab, wait a few minutes and result of whether you have it. It's a seriously good product and has a high a chance of success. Equally I like GDR multi compatibility with its test and while not as quick as AVCT has fantastic potential to really help with the Corona fight.

AVCT will probably slowly move up as its MCap is fairly high at its point in maturity, GDR should have a number of re-rates as the MCap is simply too low at this. I expect to see GDR hitting £2 within a week or two.

If either or both companies can continue with good new then both are going to have substantial price movements upwards for those only concerned about the share price.

With only 35 shares in issue, a product to sell, this is going to just continue to rise, yes there will be dips but the MCAP is just too low and a re-rate is coming up. The herd have yet to arrive yet. If NCYT can be at 400 then this can certainly be at 200.

Must be painful for you watching every tick up and a further loss for you. This is nicely and steadily pushing over £1. That is the next milestone as this will continue to slowly rise. If Jack you are that confident in your prediction then you don't need to worry do you...

you name alone says you should be ignored, your view is not important, it's usually right to be cautious on any share especially on AIM.

However this is a different story all together and people will be kicking themselves for not getting into this at this price. Look at what this company is offering, look at the current supply (tiny) and the need ( worldwide needing), now go and do the maths. IF you cannot see what is directly in front of your face I suggest you don't put your money into the market as clearly you are not able to understand risk and reward.

SNG are not creating a cure, they are creating a nebulized drug that help the body to either fight the infection naturally or to help the virus getting a grip in the lungs to begin with.
NCYT anything to do with testing can do multiples
GDR is yet to truly pop
AVCT has the most likely positive results with the test badly needed in 200+ countries and bottom line profits before any of the others; is the main play in my mind.

AVCT, GDR, NCYT, SNG these are the four main players which i'm having plays in. There are some others to consider YGEN, ODX but the main all have a lot of potential...

Once it breaks the £1 barrier then psychologically then a re-rate will be on the cards. Has it got the legs to do it today, or will the MM hold it back and do a tree shake at some point. There has been fantastic buying support at these levels so the MM will have to be even more ***ty than usual to test a pull back...

Application has been made for the 31,944,443 ordinary shares of 10 pence each ("Ordinary Shares") to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective and trading in the Ordinary Shares will commence on or around 8.00 a.m. on 24 April 2020.

Sorry Jim, I wish they were as I'm invested here but they are clearly sells. If you have level 2 you can simply go back and look at the trades at the time and compare. They were sells.

I did look at the trades jim and compared with the bid ask at the time of trades, they were sells.

Having compared the delayed sells with the bid ask at the time of those trades they all appear to be sells. Not what I wanted to discover...

It will be interesting to see trading after the close of the day. It will no doubt continue to show plenty of buys from yesterday. The share price is holding up well and just need to have some patience.

The MM are in full control now of the majority of covid shares. The day traders have had a great time recently but now the city boys are taking control and they will pull down the price trying to test the support levels. A sniff of good news and they spike it up and then pull it down, just look at GDR today, good news but not a good day for the traders. With SNG it comes down to the trial results in a couple of weeks from now. Good results higher price, bad result and the MM will bring this down faster than gravity can achieve. They will play with this price while we all wait with patience. Trust your research, don't rely on the MM to be fair, they don't play by the rules we think they do.